Endometrial hyperplasia in response to chronic estrogen stimulation represents which type of cellular adaptation?

Explanation

## Endometrial Hyperplasia: Hyperplasia as Adaptation **Key Point:** Hyperplasia is an increase in the NUMBER of cells in an organ or tissue, resulting in increased tissue mass. It occurs through increased cell division (mitosis) in response to growth stimuli. ### Mechanism of Endometrial Hyperplasia Chronic estrogen stimulation (unopposed by progesterone) triggers: 1. **Estrogen receptor activation** in endometrial epithelial cells 2. **Upregulation of growth factors** — particularly insulin-like growth factor (IGF) and fibroblast growth factor (FGF) 3. **Increased cell cycle progression** — G1/S checkpoint activation, cyclin-dependent kinase (CDK) upregulation 4. **Enhanced mitosis** — endometrial epithelial cells divide repeatedly 5. **Increased cell number** — tissue mass increases due to more cells, not larger cells ### Hyperplasia vs. Hypertrophy: Side-by-Side Comparison | Parameter | Hyperplasia | Hypertrophy | |-----------|-------------|------------| | **Definition** | ↑ cell number | ↑ cell size | | **Mechanism** | Cell division (mitosis) | Protein synthesis | | **Reversibility** | Fully reversible (remove stimulus) | Partially reversible | | **Organ mass** | Increased | Increased | | **Individual cell size** | Normal or small | Large | | **Example** | Endometrial hyperplasia (estrogen) | Cardiac hypertrophy (HTN) | | **Pathological risk** | Can progress to malignancy | Leads to dysfunction | **High-Yield:** Endometrial hyperplasia is a REVERSIBLE adaptation — stopping estrogen stimulation (or adding progesterone) causes the excess cells to undergo apoptosis and tissue returns to normal. **Mnemonic:** **H-H Rule** - **H**yperplasia = **H**ow many (cell NUMBER) - **H**ypertrophy = **H**ow big (cell SIZE) **Clinical Pearl:** Endometrial hyperplasia is a precancerous lesion (especially atypical hyperplasia) because continuous mitotic activity increases the risk of malignant transformation. This is why unopposed estrogen is a risk factor for endometrial cancer.